Portfolio company
Magnitude Biosciences
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company provides automated imaging technology and research services to pharmaceutical, biotechnology, and nutraceutical organisations for testing compounds using nematode worms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bullseye Bio
This company develops vascularised organoids and automated screening platforms to provide drug discovery services for pharmaceutical, academic and biotechnology organisations.
Warp Sciences
This company provides automated chemistry laboratories using robotics and artificial intelligence to synthesise and test research molecules for biotechnology and pharmaceutical organisations.
Clyde Biosciences
This company provides cardiac safety and efficacy testing services for pharmaceutical and biotechnology organisations using its proprietary cell-based assay platform.
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Biodock
This company provides a cloud-based artificial intelligence platform for microscopy image analysis, serving pharmaceutical companies and academic research institutions.
ScienceMachine
This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.
